The receptor for advanced glycation end-products (RAGE), which is known to act as a receptor for advanced glycation end-products (AGEs) in the setting of diabetes and atherosclerosis, also functions as a PRR for a variety of ligands including HMGB1 and S100/calgranulins in the setting of chronic inflammation. The gene discussed is AGER; the disease is atherosclerosis.